Suppr超能文献

雌激素水平、激素替代疗法的使用与乳腺癌之间的关系。

Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

作者信息

Colditz G A

机构信息

Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, and The Harvard Center for Cancer Prevention, Boston, MA 02115, USA.

出版信息

J Natl Cancer Inst. 1998 Jun 3;90(11):814-23. doi: 10.1093/jnci/90.11.814.

Abstract

We sought to determine the strength of the evidence suggesting that estrogen and postmenopausal replacement hormones play a role in the development of breast cancer. We reviewed the existing English language literature in MEDLINE on hormones and breast cancer, including reports on cell proliferation and endogenous hormone levels, as well as epidemiologic studies of the relationship between the use of postmenopausal hormones and the risk of breast cancer in women. A factor that increases the probability that cancer will develop in an individual has been defined as a cancer cause. The Hill criteria for demonstrating a link between environmental factors and disease were used to review the evidence for a causal relationship between female hormones and breast cancer. We found evidence of a causal relationship between these hormones and breast cancer, based on the following criteria: consistency, dose-response pattern, biologic plausibility, temporality, strength of association, and coherence. The magnitude of the increase in breast cancer risk per year of hormone use is comparable to that associated with delaying menopause by a year. The positive relationship between endogenous hormone levels in postmenopausal women and risk of breast cancer supports a biologic mechanism for the relationship between use of hormones and increased risk of this disease. The finding that the increase in risk of breast cancer associated with increasing duration of hormone use does not vary substantially across studies offers further evidence for a causal relationship. We conclude that existing evidence supports a causal relationship between use of estrogens and progestins, levels of endogenous estrogens, and breast cancer incidence in postmenopausal women. Hormones may act to promote the late stages of carcinogenesis among postmenopausal women and to facilitate the proliferation of malignant cells. Strategies that do not cause breast cancer are urgently needed for the relief of menopausal symptoms and the long-term prevention of osteoporosis and heart disease.

摘要

我们试图确定表明雌激素和绝经后替代激素在乳腺癌发生中起作用的证据强度。我们查阅了MEDLINE中关于激素与乳腺癌的现有英文文献,包括细胞增殖和内源性激素水平的报告,以及绝经后激素使用与女性乳腺癌风险关系的流行病学研究。将增加个体患癌可能性的因素定义为癌症病因。采用希尔标准来审查女性激素与乳腺癌之间因果关系的证据,该标准用于证明环境因素与疾病之间的联系。基于以下标准,我们发现了这些激素与乳腺癌之间存在因果关系的证据:一致性、剂量反应模式、生物学合理性、时间顺序、关联强度和连贯性。每年使用激素导致乳腺癌风险增加的幅度与推迟一年绝经所带来的风险增加幅度相当。绝经后女性内源性激素水平与乳腺癌风险之间的正相关支持了激素使用与该疾病风险增加之间关系的生物学机制。激素使用时间越长,乳腺癌风险增加,且不同研究中这一增加幅度差异不大,这一发现进一步证明了因果关系。我们得出结论,现有证据支持绝经后女性使用雌激素和孕激素、内源性雌激素水平与乳腺癌发病率之间存在因果关系。激素可能在绝经后女性中促进致癌作用的晚期阶段,并促进恶性细胞的增殖。迫切需要采取不会引发乳腺癌的策略来缓解更年期症状,并长期预防骨质疏松症和心脏病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验